Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17470824 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab

Study has passed its completion date and status has not been verified in more than two years.